Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2000
06/28/2000EP1011720A2 Mucosal cytotoxic t lymphocyte responses
06/28/2000EP1011719A1 Synthetic antigens for cd1-restricted immune responses
06/28/2000EP1011718A1 Anti-viral treatment with pertussis toxin b oligomer
06/28/2000EP1011708A1 Anti-peptide antibody against human cytochrome p450 3a4
06/28/2000EP1011707A1 HIV-1 gp120 V1/V2 DOMAIN EPITOPES CAPABLE OF GENERATING NEUTRALIZING ANTIBODIES
06/28/2000EP1011703A1 Nucleosome-based anti-tumor compositions
06/28/2000EP1011701A1 Extracts of salvia species having antiviral activity
06/28/2000EP1011567A1 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
06/28/2000EP1011440A1 Vaccine against lipopolysaccharide core
06/28/2000EP0915710B1 Stable radioiodine conjugates and methods for their synthesis
06/28/2000EP0754057B1 Compositions and methods for vaccines comprising alpha-galactosyl epitopes
06/28/2000EP0557418B1 A beta-type transforming growth factor
06/28/2000CN1258319A Vector
06/28/2000CN1258317A Process for expression of genes of dengue viruses
06/28/2000CN1257872A Leptospiral vaccine antigen for preventing leptospirosis
06/28/2000CN1053964C Immunochemical detection of in vivo advanced glycosylation endproducts
06/27/2000US6080850 Nucleotide sequence of s gene with modified major enhancing epitopes; for vaccines without accelerated progression of disease
06/27/2000US6080849 Mutant salmonella species with a genetically engineered msbb gene, expresses altered lipid a, has reduced induction of tumor necrosis factor and increased sensitivity to chelating agents; for agents against solid tumors
06/27/2000US6080846 Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus
06/27/2000US6080842 Amino acid sequence; for anticarcinogenic/antitumor agents and treatment of nervous system disorders such as alzheimer's/parkinson's/huntington's diseases; antiepileptic agents; cognition activators; antidepressants
06/27/2000US6080731 Dinucleoside-5', 5'-pyrophosphates administered to treat HIV
06/27/2000US6080729 Polypeptides and polynucleotides used to screen for antibacterial compounds
06/27/2000US6080725 Comprising one or more bacterial, viral or tumor-associated antigens; and one or more saponin-lipophile conjugate
06/27/2000US6080718 Useful in the identification and isolation of components involved in transmembrane receptor-mediated signaling
06/27/2000US6080717 Treatment of individual having a need to inhibit a polypeptide, comprising administering a bactericidal antagonist of the polypeptide
06/27/2000US6080589 Neisseria meningitidis capsular polysacchride conjugates
06/27/2000US6080570 Method of producing a vaccine for Swine Infertility and Respiratory Syndrome
06/27/2000US6080429 Emulsifying an active agent or an aqueous solution by adding to a solution of polymer/solvent; extracting excess solvent with an aqueous solution to produce microspheres; dehydrating drying in a fluidized bed; high speed; noncracking
06/27/2000US6080409 Immunostimulatory method
06/27/2000US6080408 Particles contain mutations to reduce gag-dependent rna-packaging of the gag gene product, eliminate reverse transcriptase, integrase activity and rnase h activity of the pol gene product through genetic manipulation; vaccines; aids
06/27/2000US6080407 Diagnostic assays for MIF
06/27/2000US6080400 Compositions for the prevention and treatment of verotoxin-induced disease
06/27/2000US6080399 Vaccine adjuvants for immunotherapy of melanoma
06/27/2000CA2134083C Prophylactic and therapeutic agents for autoimmune diseases
06/27/2000CA2076744C Viral agent associated with mystery swine disease
06/27/2000CA1341040C Pasteurella vaccine
06/27/2000CA1341039C Analogues of lhrh allowing increased antigenicity through conjugation
06/23/2000CA2256124A1 Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans
06/22/2000WO2000036124A2 Plant cell cycle genes and uses thereof
06/22/2000WO2000036111A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp
06/22/2000WO2000036107A2 Compositions and methods for therapy and diagnosis of ovarian cancer
06/22/2000WO2000036103A1 Cytokine receptor chain
06/22/2000WO2000036091A2 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
06/22/2000WO2000036089A2 Methods of immunosuppression
06/22/2000WO2000035950A2 Reagents and methods useful for detecting diseases of the breast
06/22/2000WO2000035949A1 Compositions and methods for enhancement of major histocompatibility complex class i restricted antigen presentation
06/22/2000WO2000035939A2 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035936A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035484A2 Methods and compositions for decreasing allergic reactions to surface allergens
06/22/2000WO2000035483A1 Methods and products for regulating lectin complement pathway associated complement activation
06/22/2000WO2000035482A2 Novel adjuvant for subunit or component vaccines
06/22/2000WO2000035481A2 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
06/22/2000WO2000035480A2 Peptides useful in diagnosing and treating hiv-induced acquired immune deficiency disease
06/22/2000WO2000035479A1 Synthetic virus-like particles with heterologous epitopes
06/22/2000WO2000035478A1 Treatment of papillomavirus infections
06/22/2000WO2000035477A2 Multi-component vaccine comprising at least two antigens from haemophilus influenzae
06/22/2000WO2000035476A1 In ovo vaccination of 1 type marek's disease virus
06/22/2000WO2000035474A1 Neurite derived growth factors for use in the treatment of muscular dystrophy
06/22/2000WO2000035468A1 Methods for improving growth and for reducing bacterial colonization of poultry
06/22/2000WO2000035409A2 Hiv-i fusion inhibition compounds
06/22/2000WO2000023955A8 Virus-like particles for the induction of autoantibodies
06/22/2000WO2000012709A3 Phelix: a testis-specific protein expressed in cancer
06/22/2000WO2000012703A3 Protein transport-associated molecules
06/22/2000WO2000012138A3 Cells expressing immunoregulatory molecules and uses therefor
06/22/2000WO2000012122A3 Low-molecular fragments of hyaluronic acid for the preparation of vaccines
06/22/2000WO2000011033A3 Expression and export of angiostatin and endostatin as immunofusins
06/22/2000WO2000010599A3 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
06/22/2000WO2000007624A3 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix
06/22/2000WO2000006736A3 Nucleic acids and proteins from group b streptococcus
06/22/2000WO1999057150A3 Multivalent antibody constructs
06/22/2000CA2718376A1 Novel adjuvant for subunit or component vaccines
06/22/2000CA2440933A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
06/22/2000CA2355971A1 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
06/22/2000CA2355901A1 Plant cell cycle genes and uses thereof
06/22/2000CA2355870A1 Reagents and methods useful for detecting diseases of the breast
06/22/2000CA2355650A1 Methods and compositions for decreasing allergic reactions to surface allergens
06/22/2000CA2355607A1 Anti-ccr5 antibody
06/22/2000CA2355270A1 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
06/22/2000CA2354456A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354444A1 Synthetic virus-like particles with heterologous epitopes
06/22/2000CA2354422A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354156A1 Compositions and methods for therapy and diagnosis of ovarian cancer
06/22/2000CA2354147A1 Methods of immunosuppression
06/22/2000CA2353997A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp
06/22/2000CA2353866A1 Treatment of papillomavirus infections
06/22/2000CA2320414A1 In ovo vaccination of type 1 marek's disease virus
06/22/2000CA2290220A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
06/22/2000CA2290219A1 Leptospira vaccine antigens for the prevention of leptospirosis
06/21/2000EP1010981A1 Conjugates to detect viruses and their use
06/21/2000EP1010759A1 Non-b non-c non-g hepatitis virus gene, polynucleotide, polypeptide, virion, method for separating virion, and method for detecting virus
06/21/2000EP1009859A1 Lyme disease vaccines
06/21/2000EP1009847A1 Conjugates that contain the homeodomain of antennapedia
06/21/2000EP1009846A1 Alphavirus-derived vectors useful as vaccines providing protection against paramyxovirus infection
06/21/2000EP1009831A2 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
06/21/2000EP1009829A1 Adipocyte-specific protein homologs
06/21/2000EP1009826A1 Erbb4 receptor-specific neuregulin, related ligands and uses thereof
06/21/2000EP1009821A1 Membrane-bound cytokine compositions and methods of modulating an immune response using same
06/21/2000EP1009804A1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
06/21/2000EP1009772A1 Monoclonal antibodies that bind testosterone
06/21/2000EP1009771A1 Peptides which elicit cytotoxic t cellular immunity
1 ... 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 ... 1823